Have you ever found yourself overwhelmed by the sheer complexity of artificial intelligence development? Whether you’re a seasoned developer or someone with no coding experience at all, the ...

The UK regulator has said eligible patients with prostate cancer will get early access to a radioligand therapy developed by Novartis' Advanced Accelerator Applications (AAA) subsidiary while it ...

Impact and progress Frontiers' impact Progress Report 2022 All annual reports ...

The online catalogue is suffering from intermittent problems, which our IT colleagues are working to resolve. We apologise for any inconvenience that this might cause. The catalogue makes information ...